Atomo’s refreshing, user-centered approach to design, and willingness to reimagine what has gone before, has led it to create devices that are simpler to use and so help to prevent user errors common with standard multi-component diagnostic test kits.

Committed to transforming rapid diagnostic testing with innovative, all-in-one test devices, Atomo offers best-in-class performance and excellent usability. By putting the needs of the end user first, Atomo has won the respect of frontline healthcare providers worldwide and has garnered an impressive roster of awards and commendations.

Award-winning Australian innovation

Atomo Diagnostics is a specialist medical device design innovator and original equipment manufacturing (OEM) company whose unique proprietary technologies support unmatched usability, accuracy, and safety. Headquartered in Sydney, Australia, Atomo has emerged as a global leader in the development of point of care devices for rapid diagnostic testing (RDT).


Designed for simplicity

Atomo’s device solutions have been designed specifically to address challenges associated with the use of standard RDTs in the field.  This commitment to usability and simplicity in design means that Atomo’s test devices are easy to learn and teach and so are suitable for deployment in a variety of settings, including doctor’s rooms, pharmacies, community clinics and even the home.

Atomo RDT platforms can be adapted to suit a variety of blood-based rapid diagnostic test assays and are, therefore, appropriate for a range of applications, including screening for chronic conditions and detection of infectious diseases.

Atomo’s operations are ISO 9001 and ISO 13485 certified for the design, development and manufacture of in vitro diagnostic medical devices.

mdma         sabcoha                         sahvcs       ivd

ISO 9001 13485